The Federal Trade Commission and State of New York late last month filed a lawsuit against Martin Shkreli, charging that Shkreli and Vyera Pharmaceuticals raised the price of the life-saving drug Daraprim by more than 4,000% and worked to corner the market for such drugs.
“The joint action accused Shkreli and Vyera Pharmaceuticals, formerly known as Turing Pharmaceuticals, of scheming to ‘illegally’ prevent would-be generic competitors from selling a version of Daraprim,” as Stat’s Ed Silverman reported on Jan. 27. After acquiring the drug in 2015, Shkreli, dubbed the “Pharma Bro,” and Turing raised the list price of the medication from $17.50 per tablet to $750, he added. Continue reading
Companies that pay for employer-sponsored health insurance are continually seeking ways to cut health care costs and improve the care delivered to employees, their family members and retirees.
To accomplish these goals in 2020, employers will implement more virtual care, such as telemedicine, and will focus more on high-cost claims, according to a report from National Business Group on Health (NBGH). Continue reading
Two of the biggest issues the Democratic candidates are addressing in the presidential race are economic inequality and the need to reform the health insurance system.
In 2016, Liz Kowalczyk, a health care and medical writer for The Boston Globe, rotated onto the paper’s Spotlight team for a project about race to document segregation in the city’s health care system. Soon after beginning that assignment she found an almost ideal source for one of her first articles, a nursing home worker who was diagnosed with stage three breast cancer. Continue reading
About 41 million unpaid family caregivers provided an estimated 34 billion hours of care — worth $470 billion — to their parents, spouses, partners, and friends in 2017, according to a new report from AARP’s Public Policy Institute (PPI). The report explores the growing scope and complexity of caregiving today, which includes an aging population, more family caregivers also in the paid workforce and an increasing amount of medical and nursing tasks now provided at home.
Ensuring better recognition of and support for family caregivers has become a health, economic, and social imperative, according to the report. Several co-authors discussed the analysis at a Nov. 14 press conference during the Gerontological Society of America annual meeting in Austin, Texas. Continue reading
One of the largest and most important parts of our health care system is the role employers play in providing health insurance coverage for workers, retirees, and family members. U.S. employers cover 55.1% of Americans who have health insurance, according to a report released by the U.S. Census Bureau.
By providing health insurance for more than half of all Americans, employers pay for the biggest share of health coverage in the United States. Continue reading
A recent study from the Commonwealth Fund and the Pacific Business Group on Health (PBGH) shows that developing a waste-free formulary by cutting the number of high-cost, low-value drugs in employers’ health benefit plans could save employers as much as 24% in pharmacy spending.
Concern about rising prescription drug costs has caused large self-insured employers to develop innovative formularies for the pharmacy benefit plans they provide to employees, their family members and retirees. A formulary is a list of drugs that employers and health plans include in their benefit plans for employees and members. Continue reading